The CSMD3 gene, a TSG in ovarian cancer (COSMIC; https://cancer.sanger.ac.uk/census; accessed on 1 May 2020), was the second most frequently pathogenically affected gene in HGSOC patients, besides TP53, in both age groups. The gene discussed is TP53; the disease is ovarian carcinoma.